Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

Substandard pharmaceuticals to be inspected again

Update : 12 Aug 2014, 06:57 PM

The government has issued directives for the re-inspection of 46 pharmaceuticals, including 29 companies that allegedly posed “high risk” to public health, that were earlier identified as manufacturers of substandard drugs.

In a meeting chaired by lawmaker Sheikh Fazlul Karim Selim on Sunday, the Parliamentary Standing Committee on Health Ministry directed a probe committee of drug specialists to reinspect the companies and submit a report within four months.

Dhaka University’s pharmacy department Professor ABM Faruque, who heads the probe committee and was present at Sunday’s meeting, told the Dhaka Tribune that the previous inspection reports were also discussed at the meeting at great lengths.

However, seeking anonymity, a member of the probe committee told the Dhaka Tribune that the move was a “laughable decision,” adding that the “cat-and-mouse game” of inspections and re-inspections have been going on for the past three years.

He also questioned the need for a re-inspection when two more inspections had already been carried out by the probe body.

When asked about the discontent among probe committee members, Prof Faruque admitted that it was true that some members were unhappy regarding the re-inspection, but added that the team would carry out the directive for the welfare of the people and the country.

Asked about the consequences of the past inspections, Health Secretary MM Niazuddin said actions have already been taken against some companies, but they were now continuing operations after filing writs with courts. Some of the companies whose licences were previously scrapped were now claiming to have improved their infrastructure, he added.

Echoing the secretary, Selim Barami, director at the Directorate General of Drug Administration (DGDA), said recent inspections by the DGDA have found that some of the accused companies have improved over the past few years. These companies urged the parliamentary body to carry out a fresh inspection to reassess their status, Barami added.

However, there are allegations that the accused pharmaceuticals have spent millions to bribe politicians and bureaucrats to delay the procedure of punitive action against them.

The eight-member probe committee, led by ABM Faruque, was formed following the deaths of at least 24 children who died after consuming paracetamol syrup of the Rid Pharmaceuticals Ltd in 2009.

The pool of drug specialists visited around 200 pharmaceuticals and submitted its first inspection report in 2011, identifying 62 companies as producers of fake medicines and suspending the licence of 19 companies.

Later in January 2013, the parliamentary body again directed the drug experts to re-inquire on the 62 companies and submit a fresh report in three months.

During its fresh round of investigations, the committee identified 29 companies as manufacturers of drugs that posed high risk to public health.

Recently, the drug directorate issued show-cause explanation notice to the accused pharmaceuticals as well as submitting the latest probe report at Sunday’s meeting.

Top Brokers